Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;8(2):80-85.
doi: 10.1016/j.afos.2022.06.001. Epub 2022 Jun 23.

Ultrasound for thigh muscle thickness is a valuable tool in the diagnosis of sarcopenia in Indian patients with predialysis chronic kidney disease

Namrata S Rao  1 , Abhilash Chandra  1 , Sai Saran  2 , Ayush Lohiya  3   4
Affiliations

Ultrasound for thigh muscle thickness is a valuable tool in the diagnosis of sarcopenia in Indian patients with predialysis chronic kidney disease

Namrata S Rao et al. Osteoporos Sarcopenia. 2022 Jun.

Abstract

Objectives: Patients with chronic kidney disease (CKD) are known to develop sarcopenia, an aging-related disorder, with low muscle mass, strength and physical performance. Ultrasound-derived thigh muscle and rectus femoris thickness (TMT and RFT) can be measured easily in clinical practice, but need validation for use in predialysis CKD (stages III through V) for muscle mass estimation. The study aims to compare ultrasound-derived TMT and RFT with bioelectrical impedance analysis (BIA)-derived muscle mass estimation in the diagnosis of sarcopenia in predialysis CKD.

Methods: Patients with stable CKD stage III, IV, V and not yet on dialysis were recruited, and underwent anthropometric assessment, BIA and ultrasound examination of midthigh region. Appendicular skeletal muscle index (ASMI)/height2 derived from BIA was taken as a standard for the diagnosis of low muscle mass. Gait speed and handgrip were also measured. The Asian Working Group criteria were applied. Cutoff values for low muscle mass by TMT and RFT were obtained using receiver operator curve (ROC) analysis.

Results: Of the total of 117 enrolled study participants, 52 (45%) had low muscle mass, 34 (29%) had sarcopenia, of whom 79% were male, majority (38%) were CKD stage IV and had a mean age of 58 years. Using ROC analysis, TMT cutoffs of 19 mm in males and 17 mm in females were computed. Comparison of TMT cutoffs and ASMI/h2 showed good agreement between the 2 methods using Bland-Altman plots.

Conclusions: Ultrasound-derived TMT and RFT can be used for muscle mass estimation in the diagnosis of sarcopenia.

Keywords: Bioelectrical impedance; Chronic kidney disease; Sarcopenia; Ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Receiver-operator curves for ultrasound-derived thigh muscle thickness (a) for the diagnosis of sarcopenia in male (b) and female (c).
Fig. 2
Fig. 2
Receiver-operator curves for ultrasound-derived rectus femoris thickness (a) for the diagnosis of sarcopenia in male (b) and female (c).
Fig. 3
Fig. 3
Bland-Altman plot of differences between low extremity muscle mass estimation (a: thigh muscle thickness; b: rectus femoris thickness) derived by ultrasound and bioelectrical impedance.
See this image and copyright information in PMC

References

    1. Foley RN, Wang C, Ishani A, Collins AJ, Murray AM. Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol. 2007;27:279–286. - PubMed
    1. Stenvinkel P, Carrero J, von Walden F, Ikizler TA, Nader G. Muscle wasting in end-stage renal disease promulgates premature death: established emerging and potential novel treatment strategies. Nephrol Dial Transplant. 2016;31:1070–1077. - PubMed
    1. Fouque D, Kalanter-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398. - PubMed
    1. Ortiz A, Sanchez-Nino MD. Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials. Clin Kidney J. 2019;12:110–112. - PMC - PubMed
    1. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have learned so far? J Nephrol. 2021;34:1347–1372. - PMC - PubMed